Table 2 Overview of microbiological results
| Â | Mono- culturen (%) | Co-infectionn (%) | Totaln (%) |
|---|---|---|---|
Significant BAL-culture | 11/33 (33.3) | 5/33 (15.2) | 16/33 (48.5) |
Haemophilus influenzae | 6 (18.2)e | 4 (12.1)a | 10 (30.3) |
Streptococcus pneumoniae | 1 (3.0)d | 3 (9.1) | 4 (12.1) |
Moraxella catarrhalis | 2 (6.1) | 2 (6.1)a | 4 (12.1) |
Staphylococcus aureus | 0 | 1 (3.0)c | 1 (3.0) |
Escherichia coli | 2 (6.1)b | 0 | 2 (6.1) |
Serratia marcescens | 0 | 1 (3.0)c | 1 (3.0) |
Commensal flora | Â | Â | 15 (45.4) |
< 10 4 cfu/ml potential pathogens in BAL |  |  | 2 (6.1) |
Viral infection n (%) | 5/32 (15.6) | 2/32 (6.3) | 7/32 (21.9) |
Respiratory syncytial virus | 2 a | 1b | 3 |
Adenovirus | 0 | 1b | 1 |
Cytomegalovirus | 1 | 0 | 1 |
Enterovirus (not polio) | 0 | 1c | 1 |
Coronavirus E229 | 1d | 0 | 1 |
Human metapneumovirus | 1 | 0 | 1 |
Parainfluenzavirus type 3 | 0 | 1c | 1 |
No viral infection detected n (%) | Â | Â | 25/32 (78.1) |
Atypical microorganism | positive | negative | Total |
Mycoplasma pneumoniae | 1e | 18 | 1/19 |
Chlamydophila pneumoniae | 0 | 14/14 | 0/14 |